Use of the FilmArray system for detection of Zaire ebolavirus in a small hospital in Bo, Sierra Leone

Journal of Clinical Microbiology

Volumn 53, Issue 7, 2015, Pages 2368-2370

  Leski, Tomasz A ^a   Ansumana, Rashid ^b,c,d   Taitt, Chris R ^a   Lamin, Joseph M ^b   Bangura, Umaru ^b   Lahai, Joseph ^b   Mbayo, George ^e   Kanneh, Mohamed B ^e   Bawo, Ben ^e   Bockarie, Alfred S ^b   Scullion, Matt ^f   Phillips, Cynthia L ^f   Horner, Cynthia P ^e   Jacobsen, Kathryn H ^g   Stenger, David A ^a  

^a NAVAL RESEARCH LABORATORY   (United States)

^b Mercy Hospital Research Laboratory   (Sierra Leone)

^c NJALA UNIVERSITY   (Sierra Leone)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e Mercy Hospital   (Sierra Leone)

^f BIOMÉRIEUX   (France)

^g GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; FILMARRAY SYSTEM; FOLLOW UP; HUMAN; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIERRA LEONE; THROAT CULTURE; URINALYSIS; VIRUS DETECTION; VIRUS EXAMINATION; VIRUS IDENTIFICATION; ZAIRE EBOLAVIRUS; BLOOD; EBOLAVIRUS; GENETICS; HEMORRHAGIC FEVER, EBOLA; HOSPITAL; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PHARYNX; PROCEDURES; VIROLOGY;

EBOLA VIRUS; ZAIRE EBOLAVIRUS;

BLOOD; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HOSPITALS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; PHARYNX; SIERRA LEONE; VIROLOGY;

EID: 84932624859     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00527-15     Document Type: Article

References (7)

1. Ansumana R, Malanoski AP, Bockarie AS, Sundufu AJ, Jimmy DH, Bangura U, Jacobsen KH, Lin B, Stenger DA. 2010. Enabling methods for community health mapping in developing countries. Int J Health Geogr 9:56. http://dx.doi.org/10.1186/1476-072X-9-56.
2. BioFire Defense. 2015. FilmArray BioSurveillance System: Fully Automated BioDetection. BioFire Defense, Salt Lake City, Utah. http://biofiredefense.com/filmarray/. Accessed 7 January 2015.
3. US Food and Drug Administration. 2014. Emergency use authorization. US Food and Drug Administration, Silver Spring, Maryland. http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm. Accessed 7 January 2015.
4. Centers for Disease Control and Prevention and World Health Organization. 1998. Infection control for viral haemorrhagic fevers in the African health care setting. Centers for Disease Control and Prevention, Atlanta, GA.
5. Sterk E. 2008. Filovirus haemorrhagic fever guideline. Médecins Sans Frontières, Barcelona, Spain.
6. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. 2007. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 196(Suppl 2):S142-S147. http://dx.doi.org/10.1086/520545.
7. Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Stroher U, Uyeki TM, Ribner BS, Emory Serious Communicable Diseases Unit. 2014. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371:2402-2409. http://dx.doi.org/10.1056/NEJMoa1409838.